These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31849155)

  • 81. The Impact of De-escalation of Antianginal Medications on Health Status After Percutaneous Coronary Intervention.
    Qintar M; Towheed A; Tang F; Salisbury AC; Ho PM; Grantham JA; Spertus JA; Arnold SV
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29054844
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Nicorandil, a hybrid between nitrate and ATP-sensitive potassium channel opener, preconditions human heart to ischemia during percutaneous transluminal coronary angioplasty.
    Yasuda T; Hashimura K; Matsu-ura Y; Kato Y; Ueda T; Mori I; Kijima Y
    Jpn Circ J; 2001 Jun; 65(6):526-30. PubMed ID: 11407735
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Hypertension is associated with increased mortality in patients with ischaemic heart disease after revascularization with percutaneous coronary intervention - a report from SCAAR.
    Saluveer O; Redfors B; Angerås O; Dworeck C; Haraldsson I; Ljungman C; Petursson P; Odenstedt J; Ioanes D; Lundgren P; Völz S; Råmunddal T; Andersson B; Omerovic E; Bergh N
    Blood Press; 2017 Jun; 26(3):166-173. PubMed ID: 28092977
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Inhibition of Rho-kinase by fasudil preventing anginal attacks associated with spastic angina: a case report].
    Hiroki J; Fukumoto Y; Shimokawa H; Hirooka Y; Takeshita A
    J Cardiol; 2004 Oct; 44(4):161-4. PubMed ID: 15532247
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Impact of Clinical Presentation (Stable Angina Pectoris vs Unstable Angina Pectoris or Non-ST-Elevation Myocardial Infarction vs ST-Elevation Myocardial Infarction) on Long-Term Outcomes in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents.
    Giustino G; Baber U; Stefanini GG; Aquino M; Stone GW; Sartori S; Steg PG; Wijns W; Smits PC; Jeger RV; Leon MB; Windecker S; Serruys PW; Morice MC; Camenzind E; Weisz G; Kandzari D; Dangas GD; Mastoris I; Von Birgelen C; Galatius S; Kimura T; Mikhail G; Itchhaporia D; Mehta L; Ortega R; Kim HS; Valgimigli M; Kastrati A; Chieffo A; Mehran R
    Am J Cardiol; 2015 Sep; 116(6):845-52. PubMed ID: 26174605
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Nitroglycerin infusion after percutaneous coronary intervention does not influence short- and long-term outcome--a prospective NAPI (Nitroglycerin Administration after Percutaneous Intervention) study.
    Foryś J; Peruga J; Plewka M; Lipiec P; Jasińska A; Krzemińska-Pakuła M; Kasprzak J
    Kardiol Pol; 2007 Jul; 65(7):789-803; discussion 804-5. PubMed ID: 17694461
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Current management and quality of life of patients with acute coronary syndrome undergoing percutaneous coronary intervention in Greece: 12-Month results from antiplatelet therapy observational study II (APTOR II).
    Pavlides G; Drossinos V; Dafni C; Altsitzoglou P; Antoniadis A; Manolis AS; Tsioufis C; Goudevenos I; Kochiadakis G; Alexopoulos D
    Hellenic J Cardiol; 2013; 54(4):255-63. PubMed ID: 23912917
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Nicorandil Versus Nitroglycerin for Symptomatic Relief of Angina in Patients With Slow Coronary Flow Phenomenon: A Randomized Clinical Trial.
    Sani HD; Eshraghi A; Nezafati MH; Vojdanparast M; Shahri B; Nezafati P
    J Cardiovasc Pharmacol Ther; 2015 Jul; 20(4):401-6. PubMed ID: 25701829
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Nicorandil. A review of its pharmacology and therapeutic efficacy in angina pectoris.
    Frampton J; Buckley MM; Fitton A
    Drugs; 1992 Oct; 44(4):625-55. PubMed ID: 1281076
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Outcome of percutaneous coronary intervention in unstable angina pectoris versus stable angina pectoris in two different time periods.
    Naidu SS; Polin GM; Selzer F; Laskey WK; Jacobs AK; Williams DO; Wilensky RL
    Am J Cardiol; 2006 Aug; 98(4):447-52. PubMed ID: 16893695
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Evidence for prevention of death and myocardial infarction with platelet membrane glycoprotein IIb/IIIa receptor blockade by abciximab (c7E3 Fab) among patients with unstable angina undergoing percutaneous coronary revascularization. EPIC Investigators. Evaluation of 7E3 in Preventing Ischemic Complications.
    Lincoff AM; Califf RM; Anderson KM; Weisman HF; Aguirre FV; Kleiman NS; Harrington RA; Topol EJ
    J Am Coll Cardiol; 1997 Jul; 30(1):149-56. PubMed ID: 9207636
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Effect of coronary angioplasty on electrocardiographic changes in patients with unstable angina secondary to left anterior descending coronary artery disease.
    Shawl FA; Velasco CE; Goldbaum TS; Forman MB
    J Am Coll Cardiol; 1990 Aug; 16(2):325-31. PubMed ID: 2373811
    [TBL] [Abstract][Full Text] [Related]  

  • 93. [Changes of serum hepatocyte growth factor before and after percutaneous coronary intervention in patients with unstable angina pectoris and significance there].
    Wang NF; Tong GX; Li PZ; Zhang XW; Xu J; Wu GP; Jin JF; Zhou L; Ye XH; Yang JM; Pan H
    Zhonghua Yi Xue Za Zhi; 2007 May; 87(20):1411-3. PubMed ID: 17785064
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Effects of percutaneous coronary intervention on the ambulatory blood pressure of patients with hypertension and coronary heart disease.
    Yang J; Yang X; Liu W; Cao T
    Ir J Med Sci; 2015 Dec; 184(4):845-50. PubMed ID: 25228072
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Usefulness of massive oral nicorandil in a patient with variant angina refractory to conventional treatment.
    Kurisu S; Inoue I; Kawagoe T; Ishihara M; Shimatani Y; Nishioka K; Nakamura S; Umemura T; Yoshida M
    Intern Med; 2003 Feb; 42(2):163-7. PubMed ID: 12636235
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Acute effects of nicardipine and esmolol on the cardiac cycle, intracardiac hemodynamic and endothelial shear stress in patients with unstable angina pectoris and moderate coronary stenosis: results from single center, randomized study.
    Chen SL; Hu ZY; Zhang JJ; Ye F; Kan J; Xu T; Liu ZZ; Zhang YJ; Zhang JX; Chen M
    Cardiovasc Ther; 2012 Jun; 30(3):162-71. PubMed ID: 22099625
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Effect of nicorandil on abnormal coronary flow reserve assessed by exercise 201Tl scintigraphy in patients with angina pectoris and nearly normal coronary arteriograms.
    Yamabe H; Namura H; Yano T; Fujita H; Kim S; Iwahashi M; Maeda K; Yokoyama M
    Cardiovasc Drugs Ther; 1995 Dec; 9(6):755-61. PubMed ID: 8850379
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Preservation of myocardial viability within the risk area by intravenous nicorandil before primary coronary intervention in patients with acute myocardial infarction.
    Umemura S; Nakamura S; Sugiura T; Tsuka Y; Shimojo M; Baden M; Iwasaka T
    Nucl Med Commun; 2008 Nov; 29(11):956-62. PubMed ID: 18836373
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Combination of Activating Blood Circulation and Detoxifying Chinese Medicines Played an Anti-Inflammatory Role in Unstable Angina Patients after Percutaneous Coronary Intervention: A Multicenter, Open-Labeled, Randomized Controlled Trial.
    Ma XJ; Duan WH; Zhang Y; Gao J; Guan BY; Chen KJ; Shi DZ
    Chin J Integr Med; 2021 Nov; 27(11):803-810. PubMed ID: 34532749
    [TBL] [Abstract][Full Text] [Related]  

  • 100. The Effect of Percutaneous Coronary Intervention on QT Dispersion and the Association Between Them: A Systematic Review.
    Dahrab M; Gaddipati SP; Patel KB; Patel T; Gaddam AR; Jain M; Gudi TR; Meenashi Sundaram D; Mahfooz K; Vasavada AM
    Cureus; 2023 Mar; 15(3):e36226. PubMed ID: 37065409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.